159 results
Page 4 of 8
8-K
EX-99.1
i9by5yrwi4
28 Jan 20
Other Events
4:35pm
8-K
EX-99.2
36ch1 do3
28 Jan 20
Other Events
4:35pm
8-K
EX-99.1
tl8jayvm
6 Jan 20
Dyadic Reports Continued Positive Business Trends and Scientific Results in Fourth Quarter 2019
4:25pm
8-K
EX-99.1
q4b5yd4o0
5 Jul 19
Dyadic Extends Research and Development Agreement with VTT
3:55pm
8-K
EX-99.1
ofsr oe9t26pp
27 Jun 19
Dyadic Announces Appointment of Ping Rawson to CFO
4:37pm
8-K
EX-99.1
3msd s5bv06w7vg3
9 May 19
Dyadic Reports First Quarter Financial Results and Recent Developments
4:13pm
10-Q
t8e3kc byx
9 May 19
Quarterly report
4:11pm
8-K
EX-99.1
4snsjd1t9u15vqrt
8 May 19
Dyadic andĀ Serum InstituteĀ of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
4:26pm
8-K
EX-99.1
d95ml965o at4qcn6czh
8 May 19
Dyadic Announces Sub-Licensing Agreement with Alphazyme
3:15pm
8-K
EX-10.2
yr9qltve0mc
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
8-K
EX-99.1
fxk8 sghhgc0e
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
8-K
EX-99.1
ojz4ccjou96g7ri
15 Apr 19
Dyadic Announces Uplisting to the Nasdaq Capital Market
11:08am
8-K
EX-99.1
8cw 1946zs
27 Mar 19
Dyadic Reports 2018 Year End Results and Recent Developments
4:32pm
10-K
cq6owu
27 Mar 19
Annual report
4:30pm
8-K
EX-99.1
13n94ke3pzsxq2ipgh
13 Feb 19
Dyadic Announces Effectiveness of Form 10
12:17pm
10-12G/A
z60jv490
8 Feb 19
Registration of securities (amended)
5:26pm
10-12G
EX-10.4
lg4el
14 Jan 19
Registration of securities
5:23pm